Price Wealth’s Editas Medicine EDIT Stock Holding History

Price Wealth’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,913	Closed	-$47K	–	292
2019 Q2	$47K	Buy	+1,913	New	+$45.7K	0.02%	123

Other funds holding EDIT

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Price Wealth's EDIT Position: Q3 2019 in Review

Price Wealth sold out of Editas Medicine (EDIT) in Q3 2019, closing a stake of 1,913 shares — an estimated $47K sold.

Price Wealth first reported a position in EDIT in Q2 2019 and held it in 1 quarter. The position peaked at $47K in Q2 2019. 187 funds tracked by Wall St. Rank hold EDIT as of Q3 2019.

Price Wealth reported no remaining Editas Medicine position as of Q3 2019 after selling out during the quarter.
Price Wealth sold 1,913 Editas Medicine shares in Q3 2019, an estimated $47K.
Price Wealth first reported a position in Editas Medicine in Q2 2019 and held it in 1 quarter.
Price Wealth's Editas Medicine position peaked at $47K in Q2 2019.
187 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2019.

Based on Price Wealth's 13F filing for Q3 2019, filed 25 Oct 2019.